Barely Significant
← all excerpts

Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large B-cell lymphoma cells and their association with clinical features.

Cancer Med · 2016 · PMC4873606 · PMID 27184832

Europe PMCDOI
1
hedged sentence
0.0990
closest p · 2.0× alpha
0.0990
boldest claim

The sentences

showed a trendP = 0.099so close (0.05 < p ≤ 0.1)
In the CHOP(‐like) chemotherapy group, patients with SH3BP5 + DLBCL showed a trend toward shorter OS than those with SH3BP5 − DLBCL ( P = 0.099, 5‐year OS; 48% [95% CI; 34–60%] and 74% [95% CI; 55–86%], respectively; Fig. 2 B), and OS for the patients with LMO3 + DLBCL also showed a trend toward reduced OS compared to those with LMO3 − DLBCL ( P = 0.067, 5‐year OS; 46% [95% CI; 28–61%] and 61% [95% CI; 47–73%], respectively; Fig. 2 E).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.